Almac Group

About Almac Group

A CRO / Clinical Trials player with a presence on the SNMMI floor; commercial activity worth a closer look.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• PR Newswire · 2026-02-15
  Almac Group announces Phase II readout for lead theranostic candidate
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Nuclear Medicine Today · 2026-05-20
  Almac Group expands cyclotron capacity to meet Lu-177 demand
  The work builds on more than a decade of radiochemistry collaboration.
• STAT News · 2026-04-13
  Almac Group signs supply agreement to support late-stage trials
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Imaging Wire · 2026-03-18
  Almac Group appoints new Chief Medical Officer ahead of pivotal trial
  The work builds on more than a decade of radiochemistry collaboration.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.